473 filings
8-K
MTNB
Matinas Biopharma Holdings Inc
5 Apr 24
Matinas BioPharma Announces Registered Direct Offering of $10 Million
7:00am
424B5
MTNB
Matinas Biopharma Holdings Inc
4 Apr 24
Prospectus supplement for primary offering
4:15pm
8-K
MTNB
Matinas Biopharma Holdings Inc
28 Mar 24
Regulation FD Disclosure
9:00am
8-K
MTNB
Matinas Biopharma Holdings Inc
27 Mar 24
Matinas BioPharma Reports 2023 Financial Results and Provides a Business Update
4:22pm
10-K
2023 FY
MTNB
Matinas Biopharma Holdings Inc
Annual report
27 Mar 24
4:02pm
8-K
zr9xer57
25 Mar 24
Matinas BioPharma Announces Positive in vivo Safety Data with its Oral LNC-Docetaxel Formulation
8:05am
8-K
bkv69w
22 Mar 24
Regulation FD Disclosure
9:20am
8-K
1t7zcsa17ebhb0 atz4n
22 Mar 24
Other Events
6:35am
8-K
03t8uo t6bwa6i2wimwc
26 Feb 24
Regulation FD Disclosure
8:05am
8-K
af84fls dc1nx
20 Feb 24
Regulation FD Disclosure
7:35am
8-K
38h5qlth878ov0q23t
9 Jan 24
Regulation FD Disclosure
7:30am
8-K
zay4q krha1smhe5b
27 Dec 23
In an acute psoriasis model, data show reductions in tissue IL-17A mRNA and improvement in clinical disease markers including skin lesions
7:40am
8-K
7sl49nvnw4c3ypg
21 Dec 23
Matinas BioPharma Provides Update to MAT2203 Regulatory and Development Pathway Following Feedback from FDA
7:40am
4
snx07sib
15 Dec 23
Matinas BioPharma / Theresa Matkovits ownership change
9:46pm
4
1kmv29otr95wz1 0aik
15 Dec 23
Matinas BioPharma / Thomas Hoover ownership change
9:46pm
4
v4gb6bbynjk nonks
15 Dec 23
Matinas BioPharma / Keith A Kucinski ownership change
9:46pm
4
cvlf5p918io4dahmko
15 Dec 23
Matinas BioPharma / Hui Liu ownership change
9:46pm
4
6s8428 y63
15 Dec 23
Matinas BioPharma / Jerome D Jabbour ownership change
9:46pm
4
ze78gs7a6q6we1hum3r1
15 Dec 23
Matinas BioPharma / James J. Ferguson III ownership change
9:46pm
8-K
50f5 bowdp38txn
20 Nov 23
Regulation FD Disclosure
7:30am